Literature DB >> 16099460

Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins.

Guy R Sander1, Adrian G Cummins, Tanya Henshall, Barry C Powell.   

Abstract

Coeliac disease is a chronic enteropathy caused by the ingestion of wheat gliadin and other cereal prolamines derived from rye and barley. In the present work, we investigated the mechanisms underlying altered barrier function properties exerted by gliadin-derived peptides in human Caco-2 intestinal epithelial cells. We demonstrate that gliadin alters barrier function almost immediately by decreasing transepithelial resistance and increasing permeability to small molecules (4 kDa). Gliadin caused a reorganisation of actin filaments and altered expression of the tight junction proteins occludin, claudin-3 and claudin-4, the TJ-associated protein ZO-1 and the adherens junction protein E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099460     DOI: 10.1016/j.febslet.2005.07.066

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  62 in total

1.  Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.

Authors:  S M Stenman; K Lindfors; J I Venäläinen; A Hautala; P T Männistö; J A Garcia-Horsman; A Kaukovirta-Norja; S Auriola; T Mauriala; M Mäki; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2010-06-15       Impact factor: 4.330

Review 2.  Is gluten a cause of gastrointestinal symptoms in people without celiac disease?

Authors:  Jessica R Biesiekierski; Jane G Muir; Peter R Gibson
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

3.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

Review 4.  The intestinal epithelial barrier: a therapeutic target?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-16       Impact factor: 46.802

Review 5.  The Urothelium: Life in a Liquid Environment.

Authors:  Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Physiol Rev       Date:  2020-03-19       Impact factor: 37.312

6.  PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium.

Authors:  Vuk Uskoković; Phin Peng Lee; Laura A Walsh; Kathleen E Fischer; Tejal A Desai
Journal:  Biomaterials       Date:  2011-11-23       Impact factor: 12.479

7.  Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.

Authors:  Vuk Uskoković; Kunwoo Lee; Phin Peng Lee; Kathleen E Fischer; Tejal A Desai
Journal:  ACS Nano       Date:  2012-08-24       Impact factor: 15.881

8.  Serological responses to microbial antigens in celiac disease patients during a gluten-free diet.

Authors:  Sara Ashorn; Tuuli Välineva; Katri Kaukinen; Merja Ashorn; Jonathan Braun; Hanna Raukola; Immo Rantala; Pekka Collin; Markku Mäki; Tiina Luukkaala; Sari Iltanen
Journal:  J Clin Immunol       Date:  2008-11-06       Impact factor: 8.317

9.  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Authors:  D Bernardo; J A Garrote; Y Allegretti; A León; E Gómez; J F Bermejo-Martin; C Calvo; S Riestra; L Fernández-Salazar; A Blanco-Quirós; F Chirdo; E Arranz
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

10.  Host responses to intestinal microbial antigens in gluten-sensitive mice.

Authors:  Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.